Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-534"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20100921.19.2-534"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, I consider that progress has been made in this text, including on two fundamental aspects: the need for labelling if nanoparticles are present in a product and, more importantly, the fact that each of these nanosubstances will also be subject to separate evaluation, which is not currently the case. Progress has also been made in terms of the possibility of excluding endocrine disrupters from substances used, with specific and properly applicable exclusion criteria.
But – there is a but – we disagree on the actual resources for the European Chemicals Agency (ECHA), because that agency’s mission should be to evaluate and authorise biocidal products.
However, we have just extended the ECHA’s mission; we agree with that, but extending it means giving the ECHA the resources to really do its job. We cannot ask the ECHA to do a lot more work, to reduce substance evaluation times, while, at the same time, reducing its resources. If we do so, we risk coming up against simplified assessments, which may well be fast, but which will be superficial and therefore inadequate.
That is why I call on you, Mrs Klaß, to reconsider your budgetary proposal concerning the ECHA missions in this dossier. As it stands, I must say that your proposal is not a serious one, and this will affect the standard of work of that European institution, which is essential to the safety of European citizens and consumers.
This is an important issue. You cannot demand more if the resources are not available, or else the ECHA will just be an administrative agency which responds to the industrial lobby."@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples